Limitations of the driver/passenger model in cancer prevention

Mary K. Kuhner, Rumen Kostadinov, Brian J. Reid

Research output: Contribution to journalArticle

Abstract

Mutations detected in cancers are often divided into "drivers" and "passengers."We suggest that this classification is potentially misleading for purposes of early detection and prevention. Specifically, some mutations are frequent in tumors and thus appear to be drivers, but are poor predictors of cancer; other mutations are individually rare and thus appear to be passengers, but may collectively explain a large proportion of risk. The assumptions bundled into the terms "driver" and "passenger" can lead to misunderstandings of neoplastic progression, with unintended consequences including overdiagnosis, overtreatment, and failure to identify the true sources of risk. We argue that samples from healthy, benign, or neoplastic tissues are critical for evaluating the risk of future cancer posed bymutations in a given gene. Cancer Prev Res; 9(5); 335-8.

Original languageEnglish (US)
Pages (from-to)335-338
Number of pages4
JournalCancer Prevention Research
Volume9
Issue number5
DOIs
StatePublished - May 1 2016

Fingerprint

Neoplasms
Mutation
Genes
Medical Overuse

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Limitations of the driver/passenger model in cancer prevention. / Kuhner, Mary K.; Kostadinov, Rumen; Reid, Brian J.

In: Cancer Prevention Research, Vol. 9, No. 5, 01.05.2016, p. 335-338.

Research output: Contribution to journalArticle

Kuhner, Mary K. ; Kostadinov, Rumen ; Reid, Brian J. / Limitations of the driver/passenger model in cancer prevention. In: Cancer Prevention Research. 2016 ; Vol. 9, No. 5. pp. 335-338.
@article{24c2a5dff80d4aa4b98111a6ecf980f0,
title = "Limitations of the driver/passenger model in cancer prevention",
abstract = "Mutations detected in cancers are often divided into {"}drivers{"} and {"}passengers.{"}We suggest that this classification is potentially misleading for purposes of early detection and prevention. Specifically, some mutations are frequent in tumors and thus appear to be drivers, but are poor predictors of cancer; other mutations are individually rare and thus appear to be passengers, but may collectively explain a large proportion of risk. The assumptions bundled into the terms {"}driver{"} and {"}passenger{"} can lead to misunderstandings of neoplastic progression, with unintended consequences including overdiagnosis, overtreatment, and failure to identify the true sources of risk. We argue that samples from healthy, benign, or neoplastic tissues are critical for evaluating the risk of future cancer posed bymutations in a given gene. Cancer Prev Res; 9(5); 335-8.",
author = "Kuhner, {Mary K.} and Rumen Kostadinov and Reid, {Brian J.}",
year = "2016",
month = "5",
day = "1",
doi = "10.1158/1940-6207.CAPR-15-0343",
language = "English (US)",
volume = "9",
pages = "335--338",
journal = "Cancer Prevention Research",
issn = "1940-6207",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - Limitations of the driver/passenger model in cancer prevention

AU - Kuhner, Mary K.

AU - Kostadinov, Rumen

AU - Reid, Brian J.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Mutations detected in cancers are often divided into "drivers" and "passengers."We suggest that this classification is potentially misleading for purposes of early detection and prevention. Specifically, some mutations are frequent in tumors and thus appear to be drivers, but are poor predictors of cancer; other mutations are individually rare and thus appear to be passengers, but may collectively explain a large proportion of risk. The assumptions bundled into the terms "driver" and "passenger" can lead to misunderstandings of neoplastic progression, with unintended consequences including overdiagnosis, overtreatment, and failure to identify the true sources of risk. We argue that samples from healthy, benign, or neoplastic tissues are critical for evaluating the risk of future cancer posed bymutations in a given gene. Cancer Prev Res; 9(5); 335-8.

AB - Mutations detected in cancers are often divided into "drivers" and "passengers."We suggest that this classification is potentially misleading for purposes of early detection and prevention. Specifically, some mutations are frequent in tumors and thus appear to be drivers, but are poor predictors of cancer; other mutations are individually rare and thus appear to be passengers, but may collectively explain a large proportion of risk. The assumptions bundled into the terms "driver" and "passenger" can lead to misunderstandings of neoplastic progression, with unintended consequences including overdiagnosis, overtreatment, and failure to identify the true sources of risk. We argue that samples from healthy, benign, or neoplastic tissues are critical for evaluating the risk of future cancer posed bymutations in a given gene. Cancer Prev Res; 9(5); 335-8.

UR - http://www.scopus.com/inward/record.url?scp=84969972242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969972242&partnerID=8YFLogxK

U2 - 10.1158/1940-6207.CAPR-15-0343

DO - 10.1158/1940-6207.CAPR-15-0343

M3 - Article

C2 - 26932841

AN - SCOPUS:84969972242

VL - 9

SP - 335

EP - 338

JO - Cancer Prevention Research

JF - Cancer Prevention Research

SN - 1940-6207

IS - 5

ER -